Bai, N., Khazaei, M., van Eeden, S.F. and Laher, I. (2007) The Pharmacology of Particulate Matter Air Pollution-Induced Cardiovascular Dysfunction. Pharmacology & Therapeutics, 113, 16-29.
https://doi.org/10.1016/j.pharmthera.2006.06.005

has been cited by the following article:

• TITLE: Risk of Cardiovascular Disease Associated with the Exposure of Particulate Matter (PM2.5): Review

  AUTHORS: Rabina Sinkemani, Arjun Sinkemani, Xiaobo Li, Rui Chen

  KEYWORDS: Particulate Matter, Air Pollution, Cardiovascular Disease, Risk

  JOURNAL NAME: Journal of Environmental Protection, Vol.9 No.6, May 31, 2018

  ABSTRACT: Association of particulate matter (PM2.5) increases the risk of cardiovascular disease. Experimental and clinical evidences suggested that PM2.5 is directly linked with cardiovascular disease. PM2.5 also plays an important role in the biological mechanisms influencing in the cardiovascular system. Here in this review, we tried to discuss that PM2.5 is associated with the increase risk of cardiovascular disease in which PM2.5 air pollutants enter through the alveolar of the lungs through the systemic circulation inducing cardiovascular disease. More studies need to be done for further understanding to clarify the interactions of PM2.5 components associated with cardiovascular disease.